US EditionPublished • loading... • Updated
This weight-loss pill by Lilly could be FDA-approved by end of 2025
Summary by Fast Company
2 Articles
2 Articles
The US Food and Drug Administration (FDA) could speed up approval of Eli Lilly's experimental weight loss pill
·Belgrade, Serbia
Read Full Article
This weight-loss pill by Lilly could be FDA-approved by end of 2025
Eli Lilly’s experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said. Analysts speculate that the drug, orforglipron, is a viable candidate given the growing cost burden of expensive injectable weight-loss drugs and the fact that Lilly is expanding its U.S. manufacturing — issues the Trump Administration has prioritiz…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
